Mar 27 2025 10 mins
Dive deep into the world of nutritional innovation as Peter Davey, CEO of Clover Corporation Limited, reveals how this Australian company has become a global leader in microencapsulation technology. With manufacturing facilities spanning Australia, New Zealand, and Ecuador, Clover has positioned itself as an essential supplier to the world's infant formula manufacturers – with an impressive 98% of their production exported globally.
The conversation unpacks Clover's remarkable financial rebound, achieving 38% revenue growth despite challenging global market conditions. Peter explains their dual-strategy approach: vertical integration into their supply chain (including their strategic Ecuador fish oil extraction facility) and horizontal expansion into new products and markets. This approach has not only improved margins by 270 basis points but has opened exciting new market opportunities beyond traditional infant formula.
Most fascinating is Clover's innovation pipeline, including their patented Gelphorm technology that achieves what was previously considered impossible – incorporating omega-3 into UHT products. This breakthrough has already gained traction in North America and is poised for expansion into Europe and Asia. As global birth rates decline (China's has halved in six years), Peter shares how Clover is pivoting with their customers to adult nutrition, sports formulas, and even pet food applications, demonstrating remarkable adaptability.